This latest twist during the Lykos Therapeutics saga threatens A serious overhaul of the organization’s method and course, with Musk ally and billionaire Trader Antonio Gracias appearing to choose to acquire the corporation back again towards its nonprofit drug improvement roots and a more Doblinite philosophy.Disclaimer: copyright Highlight and